Risperdal is an atypical antipsychotic drug for the treatment of bipolar disorder and schizophrenia. However, these types of medications have been associated with causing serious, potentially life-threatening health consequences.
Johnson & Johnson Must Pay $1.1 Billion Penalty in Ark. Risperdal Case
Johnson & Johnson was ordered to pay more than $1.1 billion by an Arkansas judge after the jury found that the company’s officials misled doctors and patients about the risks of the antipsychotic drug, Risperdal.
Judge Tim Fox, in Little...
Johnson & Johnson to Pay $5.9 Million in Risperdal Settlement
Earlier this month, a Johnson & Johnson (J&J) subsidiary agreed to pay $5.9 million to resolve a suit alleging that the drug company heavily marketed Risperdal, the antipsychotic drug, as safe, despite knowing about the serious risks,...